CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]
SynGenSys, a biotechnology company developing synthetic gene promoter systems, has [...]
Boston-based Strand Therapeutics has raised $153 million in a Series [...]
Centauri aims to start first-in-human clinical study for broad-spectrum immunotherapy [...]
A new study from researchers in Japan has uncovered a [...]
Scancell has reported updated results from its Phase 2 SCOPE [...]
The National Institute for Health and Care Excellence (NICE) has [...]
A new whitepaper from Novotech has outlined how in-vivo CAR-T [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
Funding to advance EO2463 through Phase 1/2 and prepare for [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
